Type 2 Diabetes News and Research RSS Feed - Type 2 Diabetes News and Research

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company. [More]
UT Southwestern researchers discover crucial link between high insulin levels and obesity pathways

UT Southwestern researchers discover crucial link between high insulin levels and obesity pathways

UT Southwestern Medical Center researchers have identified a crucial link between high levels of insulin and pathways that lead to obesity, a finding that may have important implications when treating diabetes. [More]
Malaysia set to become the new healthcare investor destination, says Frost & Sullivan

Malaysia set to become the new healthcare investor destination, says Frost & Sullivan

Malaysia is turning out to be the new healthcare investor destination as a proactive government and burgeoning aging population fuel the demand for healthcare services. [More]
Study finds a host of new clues on gene-environment interactions in Crohn's disease

Study finds a host of new clues on gene-environment interactions in Crohn's disease

A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America. [More]
Highlights from the August issue of Mayo Clinic Health Letter

Highlights from the August issue of Mayo Clinic Health Letter

Here are highlights from the August issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. [More]
Study: Low birth weight may put African American women at higher risk for type 2 diabetes

Study: Low birth weight may put African American women at higher risk for type 2 diabetes

African American women born at a low or very low birth weight may be at a higher risk for developing type 2 diabetes. The findings, which appear in Diabetes Care, may explain in part the higher occurrence of type 2 diabetes in African American populations, which has a high prevalence of low birth weight. [More]
Losing weight: A big money-saver for individuals with Type 2 diabetes

Losing weight: A big money-saver for individuals with Type 2 diabetes

Overweight individuals with diabetes who lose weight by dieting and increasing their physical activity can reduce their health care costs by an average of more than $500 per year, according to a new study. [More]
Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen. [More]
KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME. [More]
Study helps explain why sleep becomes more fragmented with age

Study helps explain why sleep becomes more fragmented with age

As people grow older, they often have difficulty falling asleep and staying asleep, and tend to awaken too early in the morning. [More]
Lilly and Boehringer Ingelheim's Basaglar (insulin glargine injection) gets FDA's tentative approval

Lilly and Boehringer Ingelheim's Basaglar (insulin glargine injection) gets FDA's tentative approval

The U.S. Food and Drug Administration today granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes. [More]
Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment

Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment

It's time to question the common belief that patients receiving intensive blood pressure treatment are prone to falling and breaking bones. A comprehensive study in people ages 40 to 79 with diabetes, led by Karen Margolis, MD, of HealthPartners Institute for Education and Research in the US, found no evidence supporting this belief. [More]
New cholesterol guidelines can significantly help reduce cardiovascular events

New cholesterol guidelines can significantly help reduce cardiovascular events

A study from UT-Southwestern researchers found that recently introduced cholesterol guidelines would significantly reduce new cardiovascular events, when compared to treatment based on previous cholesterol guidelines. [More]
Meta-analysis shows blood pressure variability and mortality link

Meta-analysis shows blood pressure variability and mortality link

A systematic review and meta-analysis of studies investigating the link between visit-to-visit variability of blood pressure and cardiovascular disease or all-cause mortality has revealed a modest, but significant, association. [More]
Diet reduces inflammatory markers in ‘real world’ Type 2 diabetes

Diet reduces inflammatory markers in ‘real world’ Type 2 diabetes

Encouraging patients newly diagnosed with Type 2 diabetes to diet or to diet and increase their physical activity reduces markers of inflammation and their cardiovascular risk compared with usual care, real-world study findings show. [More]
Heart attack survivors who exercise vigorously are at increased risk of cardiovascular deaths

Heart attack survivors who exercise vigorously are at increased risk of cardiovascular deaths

There is strong epidemiological evidence of the importance of regular physical activity, such as brisk walking and jogging, in the management and rehabilitation of cardiovascular disease and in lowering the risk of death from other diseases such as hypertension, stroke, and type 2 diabetes. [More]
Almonds can help reduce inflammation in people with poorly controlled diabetes

Almonds can help reduce inflammation in people with poorly controlled diabetes

Evidence continues to mount supporting the role of almonds and other tree nuts as part of an overall dietary pattern that is beneficial for those with type 2 diabetes. Three new studies suggest a relationship between regular consumption of tree nuts, such as almonds, and improvement in various markers of health in type 2 diabetes. [More]
Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio. [More]
Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. [More]
BCBSIL awards grants to improve health and wellness of the people of Illinois

BCBSIL awards grants to improve health and wellness of the people of Illinois

Blue Cross and Blue Shield of Illinois is awarding $3,380,000 to nonprofit health and human service organizations that are making meaningful differences in the lives of the people of Illinois. [More]